APO RESEARCH · REPORT
Omega 3 Products
Omega-3 is an essential fatty acid (EFA), also known as a polyunsaturated fatty acid (PUFA).
Product & engineering
Understand the product.
Omega-3 is an essential fatty acid (EFA), also known as a polyunsaturated fatty acid (PUFA).
It is derived from both animal and plant sources, although Omega-3 from fish oil is the most common supplemental form.
Selected research
Market Structure
Global Omega 3 Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Omega-3 is an essential fatty acid (EFA), also known as a polyunsaturated fatty acid (PUFA).
It is derived from both animal and plant sources, although Omega-3 from fish oil is the most common supplemental form.
Global Omega 3 Products key players include Aker BioMarine, Epax, Innovix Pharma, Nordic Naturals, DSM, etc. Global five four manufacturers hold a share over 25%.
Read the full market overview
Europe is the largest market, with a share over 40%, followed by Asia-Pacific and North America, both have a share over 45%.
In terms of product, Omega 3 is the largest segment, with a share over 60%. And in terms of application, the largest application is Ordinary People, followed by Athletes and Lifters, etc.
This report provides an overview of the global Omega 3 Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Omega 3 Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Omega 3 Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Omega 3 Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Omega 3 Products Segment by Company
Epax
Aker BioMarine
Innovix Pharma
Crode
DSM
Nordic Naturals
Luhua Biomarine
KD Pharma(Marine Ingredients)
Cargill
Pharmavite
Ascenta Health
KD Pharma
Pharbio
DuPont
GSK
Natrol
Carlson Laboratories
Gowell Pharma
By-Health
OmegaBrite
Amway
NOW Foods
Optimum Nutrition
Omega 3 Products Segment by Type
Omega 3
Omega-D3
Omega 3-6-9
Omega 3 Products Segment by Application
Athletes and Lifters
Ordinary People
Others
Omega 3 Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega 3 Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omega 3 Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega 3 Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Omega 3 Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Omega 3 Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Omega 3 Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Omega 3 Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Omega 3
- Omega-D3
- Omega 3-6-9
Applications
- Athletes and Lifters
- Ordinary People
- Others
Companies covered
- Epax
- Aker BioMarine
- Innovix Pharma
- Crode
- DSM
- Nordic Naturals
- Luhua Biomarine
- KD Pharma(Marine Ingredients)
- Cargill
- Pharmavite
- Ascenta Health
- KD Pharma
- Pharbio
- DuPont
- GSK
- Natrol
- Carlson Laboratories
- Gowell Pharma
- By-Health
- OmegaBrite
- Amway
- NOW Foods
- Optimum Nutrition
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Omega 3 Products Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Omega 3 Products Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Omega 3 Products Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Omega 3 Products Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Omega 3 Products Market Dynamics
- 2.1 Omega 3 Products Industry Trends
- 2.2 Omega 3 Products Industry Drivers
- 2.3 Omega 3 Products Industry Opportunities and Challenges
- 2.4 Omega 3 Products Industry Restraints
3 Omega 3 Products Market by Manufacturers
- 3.1 Global Omega 3 Products Revenue by Manufacturers (2021-2026)
- 3.2 Global Omega 3 Products Sales by Manufacturers (2021-2026)
- 3.3 Global Omega 3 Products Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Omega 3 Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Omega 3 Products Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Omega 3 Products Manufacturers, Product Type & Application
- 3.7 Global Omega 3 Products Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Omega 3 Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Omega 3 Products Players Market Share by Revenue in 2025
- 3.8.3 2025 Omega 3 Products Tier 1, Tier 2, and Tier 3
4 Omega 3 Products Market by Type
- 4.1 Omega 3 Products Type Introduction
- 4.1.1 Omega 3
- 4.1.2 Omega-D3
- 4.1.3 Omega 3-6-9
- 4.2 Global Omega 3 Products Sales by Type
- 4.2.1 Global Omega 3 Products Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Omega 3 Products Sales by Type (2021-2032)
- 4.2.3 Global Omega 3 Products Sales Market Share by Type (2021-2032)
- 4.3 Global Omega 3 Products Revenue by Type
- 4.3.1 Global Omega 3 Products Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Omega 3 Products Revenue by Type (2021-2032)
- 4.3.3 Global Omega 3 Products Revenue Market Share by Type (2021-2032)
5 Omega 3 Products Market by Application
- 5.1 Omega 3 Products Application Introduction
- 5.1.1 Athletes and Lifters
- 5.1.2 Ordinary People
- 5.1.3 Others
- 5.2 Global Omega 3 Products Sales by Application
- 5.2.1 Global Omega 3 Products Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Omega 3 Products Sales by Application (2021-2032)
- 5.2.3 Global Omega 3 Products Sales Market Share by Application (2021-2032)
- 5.3 Global Omega 3 Products Revenue by Application
- 5.3.1 Global Omega 3 Products Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Omega 3 Products Revenue by Application (2021-2032)
- 5.3.3 Global Omega 3 Products Revenue Market Share by Application (2021-2032)
6 Global Omega 3 Products Sales by Region
- 6.1 Global Omega 3 Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Omega 3 Products Sales by Region (2021-2032)
- 6.2.1 Global Omega 3 Products Sales by Region (2021-2026)
- 6.2.2 Global Omega 3 Products Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Omega 3 Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Omega 3 Products Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Omega 3 Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Omega 3 Products Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Omega 3 Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Omega 3 Products Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Omega 3 Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Omega 3 Products Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Omega 3 Products Revenue by Region
- 7.1 Global Omega 3 Products Revenue by Region
- 7.1.1 Global Omega 3 Products Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Omega 3 Products Revenue by Region (2021-2026)
- 7.1.3 Global Omega 3 Products Revenue by Region (2027-2032)
- 7.1.4 Global Omega 3 Products Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Omega 3 Products Revenue (2021-2032)
- 7.2.2 North America Omega 3 Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Omega 3 Products Revenue (2021-2032)
- 7.3.2 Europe Omega 3 Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Omega 3 Products Revenue (2021-2032)
- 7.4.2 Asia-Pacific Omega 3 Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Omega 3 Products Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Omega 3 Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Epax
- 8.1.1 Epax Company Information
- 8.1.2 Epax Business Overview
- 8.1.3 Epax Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Epax Omega 3 Products Product Portfolio
- 8.1.5 Epax Recent Developments
- 8.2 Aker BioMarine
- 8.2.1 Aker BioMarine Company Information
- 8.2.2 Aker BioMarine Business Overview
- 8.2.3 Aker BioMarine Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Aker BioMarine Omega 3 Products Product Portfolio
- 8.2.5 Aker BioMarine Recent Developments
- 8.3 Innovix Pharma
- 8.3.1 Innovix Pharma Company Information
- 8.3.2 Innovix Pharma Business Overview
- 8.3.3 Innovix Pharma Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Innovix Pharma Omega 3 Products Product Portfolio
- 8.3.5 Innovix Pharma Recent Developments
- 8.4 Crode
- 8.4.1 Crode Company Information
- 8.4.2 Crode Business Overview
- 8.4.3 Crode Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Crode Omega 3 Products Product Portfolio
- 8.4.5 Crode Recent Developments
- 8.5 DSM
- 8.5.1 DSM Company Information
- 8.5.2 DSM Business Overview
- 8.5.3 DSM Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 DSM Omega 3 Products Product Portfolio
- 8.5.5 DSM Recent Developments
- 8.6 Nordic Naturals
- 8.6.1 Nordic Naturals Company Information
- 8.6.2 Nordic Naturals Business Overview
- 8.6.3 Nordic Naturals Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Nordic Naturals Omega 3 Products Product Portfolio
- 8.6.5 Nordic Naturals Recent Developments
- 8.7 Luhua Biomarine
- 8.7.1 Luhua Biomarine Company Information
- 8.7.2 Luhua Biomarine Business Overview
- 8.7.3 Luhua Biomarine Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Luhua Biomarine Omega 3 Products Product Portfolio
- 8.7.5 Luhua Biomarine Recent Developments
- 8.8 KD Pharma(Marine Ingredients)
- 8.8.1 KD Pharma(Marine Ingredients) Company Information
- 8.8.2 KD Pharma(Marine Ingredients) Business Overview
- 8.8.3 KD Pharma(Marine Ingredients) Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 KD Pharma(Marine Ingredients) Omega 3 Products Product Portfolio
- 8.8.5 KD Pharma(Marine Ingredients) Recent Developments
- 8.9 Cargill
- 8.9.1 Cargill Company Information
- 8.9.2 Cargill Business Overview
- 8.9.3 Cargill Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cargill Omega 3 Products Product Portfolio
- 8.9.5 Cargill Recent Developments
- 8.10 Pharmavite
- 8.10.1 Pharmavite Company Information
- 8.10.2 Pharmavite Business Overview
- 8.10.3 Pharmavite Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Pharmavite Omega 3 Products Product Portfolio
- 8.10.5 Pharmavite Recent Developments
- 8.11 Ascenta Health
- 8.11.1 Ascenta Health Company Information
- 8.11.2 Ascenta Health Business Overview
- 8.11.3 Ascenta Health Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Ascenta Health Omega 3 Products Product Portfolio
- 8.11.5 Ascenta Health Recent Developments
- 8.12 KD Pharma
- 8.12.1 KD Pharma Company Information
- 8.12.2 KD Pharma Business Overview
- 8.12.3 KD Pharma Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 KD Pharma Omega 3 Products Product Portfolio
- 8.12.5 KD Pharma Recent Developments
- 8.13 Pharbio
- 8.13.1 Pharbio Company Information
- 8.13.2 Pharbio Business Overview
- 8.13.3 Pharbio Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Pharbio Omega 3 Products Product Portfolio
- 8.13.5 Pharbio Recent Developments
- 8.14 DuPont
- 8.14.1 DuPont Company Information
- 8.14.2 DuPont Business Overview
- 8.14.3 DuPont Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 DuPont Omega 3 Products Product Portfolio
- 8.14.5 DuPont Recent Developments
- 8.15 GSK
- 8.15.1 GSK Company Information
- 8.15.2 GSK Business Overview
- 8.15.3 GSK Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 GSK Omega 3 Products Product Portfolio
- 8.15.5 GSK Recent Developments
- 8.16 Natrol
- 8.16.1 Natrol Company Information
- 8.16.2 Natrol Business Overview
- 8.16.3 Natrol Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Natrol Omega 3 Products Product Portfolio
- 8.16.5 Natrol Recent Developments
- 8.17 Carlson Laboratories
- 8.17.1 Carlson Laboratories Company Information
- 8.17.2 Carlson Laboratories Business Overview
- 8.17.3 Carlson Laboratories Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Carlson Laboratories Omega 3 Products Product Portfolio
- 8.17.5 Carlson Laboratories Recent Developments
- 8.18 Gowell Pharma
- 8.18.1 Gowell Pharma Company Information
- 8.18.2 Gowell Pharma Business Overview
- 8.18.3 Gowell Pharma Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Gowell Pharma Omega 3 Products Product Portfolio
- 8.18.5 Gowell Pharma Recent Developments
- 8.19 By-Health
- 8.19.1 By-Health Company Information
- 8.19.2 By-Health Business Overview
- 8.19.3 By-Health Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 By-Health Omega 3 Products Product Portfolio
- 8.19.5 By-Health Recent Developments
- 8.20 OmegaBrite
- 8.20.1 OmegaBrite Company Information
- 8.20.2 OmegaBrite Business Overview
- 8.20.3 OmegaBrite Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 OmegaBrite Omega 3 Products Product Portfolio
- 8.20.5 OmegaBrite Recent Developments
- 8.21 Amway
- 8.21.1 Amway Company Information
- 8.21.2 Amway Business Overview
- 8.21.3 Amway Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Amway Omega 3 Products Product Portfolio
- 8.21.5 Amway Recent Developments
- 8.22 NOW Foods
- 8.22.1 NOW Foods Company Information
- 8.22.2 NOW Foods Business Overview
- 8.22.3 NOW Foods Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 NOW Foods Omega 3 Products Product Portfolio
- 8.22.5 NOW Foods Recent Developments
- 8.23 Optimum Nutrition
- 8.23.1 Optimum Nutrition Company Information
- 8.23.2 Optimum Nutrition Business Overview
- 8.23.3 Optimum Nutrition Omega 3 Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 Optimum Nutrition Omega 3 Products Product Portfolio
- 8.23.5 Optimum Nutrition Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Omega 3 Products Value Chain Analysis
- 9.1.1 Omega 3 Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Omega 3 Products Production Mode & Process
- 9.2 Omega 3 Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Omega 3 Products Distributors
- 9.2.3 Omega 3 Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst